Status:
COMPLETED
Ultrasound Biomicroscopy - Apoptosis
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Princess Margaret Hospital, Canada
Conditions:
Lymphoma
Lymphoma, Non-Hodgkin
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
A group of researchers at the Ontario Cancer Institute/Princess Margaret Hospital have discovered that a very specific form of cell death 'apoptosis' can be detected using high-frequency ultrasound im...
Eligibility Criteria
Inclusion
- lymphoma patients with superficial lesions prior to starting chemotherapy or after relapse of disease
- patients with superficial melanoma lesions
- patients with superficial basal cell carcinoma lesions
- Informed consent
Exclusion
- \-
Key Trial Info
Start Date :
April 1 1999
Trial Type :
INTERVENTIONAL
End Date :
December 1 2004
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00188370
Start Date
April 1 1999
End Date
December 1 2004
Last Update
September 16 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9